Electronic Brachytherapy: Overused and Overpriced?
Cutis. 2015 September;96(3):153-154
September 14, 2015|Cutis
Author and Disclosure Information
The introduction of high-density radiation electronic brachytherapy (eBX) for the treatment of nonmelanoma skin cancers has induced great angst within the dermatology community. Do the benefits of eBX outweigh the treatment costs?
Acknowledgments—I would like to thank Janellen Smith, MD (Irvine, California), Joshua Spanogle, MD (Saint Augustine, Florida), and Jordan V. Wang, MBE (Philadelphia, Pennsylvania), for their constructive comments.
